- Big Bank Phobia: Not Too Big to Fail
- Expect Your Health Care in Retirement to Hit $200,000
- Why Car Prices Vary From City To City
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
- 5 Worst Home Renovation Projects
Article
Short Trade: Supernus IPO Lock-Up
Supernus share should fall now that 10 million shares under lock-up can now be sold.
07:00AM 10/31/12
Article
How to Prep for the Inevitable Bursting of the Biotech Stock Bubble
Traders need to be less cocky and more prepared for when stocks fall.
07:00AM 10/17/12
Article
AP Pharma, Delcath Systems: FDA 'Acceptance' Run-Up Trades
The biotech bull market has created a new category of swing trade catalysts.
07:05AM 10/09/12
Article
How to Trade Hemispherx Even If You Hate the Stock
Biotech swing trader Mark Messier warns to look at Hemispherx as a short-term trade, not an investment.
10:48AM 10/02/12
Article
Zogenix: Three Shots At Run-Up Trade
Get in Zogenix early before other traders start speculating over its chronic pain drug Zohydro.
08:00AM 09/26/12
Article
Acadia Pharma, Sarepta Therapeutics: How to Trade Into Trial Results
Biotech trader Mark Messier explains how to position trades ahead of two important biotech clinical trials.
07:31AM 09/19/12
Article
Dynavax: The BioRunUp Trade Into An FDA Panel
Biotech trader Mark Messier explains how to swing trade Dynavax into a Nov. 14 FDA advisory panel.
11:34AM 09/11/12